Issue Date
2020-02-27Keywords
DOWN SYNDROMEimmune dysregulation
immunodeficiency
innate immunity
review
Metadata
Show full item recordJournal
Frontiers in pediatricsDOI
10.3389/fped.2020.00073PubMed ID
32175298Item Type
ArticleOther
Language
enISSN
2296-2360ae974a485f413a2113503eed53cd6c53
10.3389/fped.2020.00073
Scopus Count
Collections
Related articles
- Altered Toll-Like Receptor Signalling in Children with Down Syndrome.
- Authors: Huggard D, Koay WJ, Kelly L, McGrane F, Ryan E, Lagan N, Roche E, Balfe J, Leahy TR, Franklin O, Moreno-Oliveira A, Melo AM, Doherty DG, Molloy EJ
- Issue date: 2019
- Altered endotoxin responsiveness in healthy children with Down syndrome.
- Authors: Huggard D, McGrane F, Lagan N, Roche E, Balfe J, Leahy TR, Franklin O, Moreno A, Melo AM, Doherty DG, Molloy EJ
- Issue date: 2018 Nov 3
- Immunomodulating activity of Pidotimod in children with Down syndrome.
- Authors: Zuccotti GV, Mameli C, Trabattoni D, Beretta S, Biasin M, Guazzarotti L, Clerici M
- Issue date: 2013 Jan-Mar
- Infections and immunodeficiency in Down syndrome.
- Authors: Ram G, Chinen J
- Issue date: 2011 Apr
- Frailty, inflammation, and immunity.
- Authors: Li H, Manwani B, Leng SX
- Issue date: 2011 Dec